Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Receivables - Net (2022 - 2025)

Historic Receivables - Net for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $448990.0.

  • bioAffinity Technologies' Receivables - Net fell 6616.93% to $448990.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $448990.0, marking a year-over-year decrease of 6616.93%. This contributed to the annual value of $1.1 million for FY2024, which is 4035.24% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Receivables - Net of $448990.0 as of Q3 2025, which was down 6616.93% from $421869.0 recorded in Q2 2025.
  • bioAffinity Technologies' Receivables - Net's 5-year high stood at $1.6 million during Q2 2024, with a 5-year trough of $9930.0 in Q3 2022.
  • For the 4-year period, bioAffinity Technologies' Receivables - Net averaged around $697075.2, with its median value being $811674.0 (2023).
  • In the last 5 years, bioAffinity Technologies' Receivables - Net skyrocketed by 1106227.59% in 2023 and then crashed by 7356.09% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Receivables - Net (Quarter) stood at $10489.0 in 2022, then surged by 7638.34% to $811674.0 in 2023, then soared by 40.35% to $1.1 million in 2024, then tumbled by 60.59% to $448990.0 in 2025.
  • Its Receivables - Net was $448990.0 in Q3 2025, compared to $421869.0 in Q2 2025 and $963744.0 in Q1 2025.